Literature DB >> 4061745

Use of the pectoralis major muscle flap for repair of a tracheoesophageal fistula.

K F Siu, W I Wei, K H Lam, J Wong.   

Abstract

A case of tracheal rupture after a Lewis-Tanner esophagectomy in a patient with carcinoma of the esophagus was complicated by the formation of a tracheoesophageal fistula after initial direct repair. The fistula was successfully treated with a pectoralis major muscle flap moved into the superior mediastinum by a sternotomy and excision of the upper part of the sternum and adjacent costal cartilages.

Entities:  

Mesh:

Year:  1985        PMID: 4061745     DOI: 10.1016/0002-9610(85)90449-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

Review 1.  The development and treatment of periprosthetic leakage after prosthetic voice restoration: a literature review and personal experience. Part II: conservative and surgical management.

Authors:  Kai J Lorenz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-18       Impact factor: 2.503

2.  The management of periprosthetic leakage in the presence of supra-oesophageal reflux after prosthetic voice rehabilitation.

Authors:  Kai J Lorenz; L Grieser; T Ehrhart; H Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-09       Impact factor: 2.503

3.  A simple surgical technique for tracheoesophageal fistula closure.

Authors:  Mieke Moerman; Hubert Vermeersch; Philippe Heylbroeck
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

Review 4.  [Surgical treatment of enlarged trachoesophageal puncture with and without supraesophageal reflux : case report and review of literature].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

Review 5.  Contemporary role of pectoralis major regional flaps in head and neck surgery.

Authors:  F Bussu; R Gallus; V Navach; R Bruschini; M Tagliabue; G Almadori; G Paludetti; L Calabrese
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.